Inhibikase Therapeutics shares owned by Susquehanna International
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Susquehanna International
from 13F filings
Historical chart of Susquehanna International investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Inhibikase Therapeutics by Susquehanna International
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $49k | 23k | 2.16 |